Drugs / OPC-262
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT00997282 | Sep 2009 → Oct 2010 | type 2 diabetes mellitus | Kyowa Kirin, Inc. | Completed | No outcome recorded |
| Phase 33 trials | ||||||
| Phase 3 | NCT01193179 | Jul 2010 → Apr 2012 | type 2 diabetes mellitus | Kyowa Kirin, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01046318 | Nov 2009 → Jul 2011 | type 2 diabetes mellitus | Kyowa Kirin, Inc. | Completed | No outcome recorded |
| Phase 3 | NCT01634282 | Aug 2009 → Jun 2011 | type 2 diabetes mellitus | Kyowa Kirin, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | OPC-262 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01634282 ↗ |
| Route | Oral | “orally administered once daily for 24 weeks” NCT00997282 ↗ |